back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2026-04-01 17:13 Tx date 2026-03-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$56,511
+3,919 vol $14.42 each |
64,519 | |
| Filed 2026-04-01 17:12 Tx date 2026-03-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-7,838 vol |
60,600 | |
| Older filings | ||||||
| Filed 2026-03-24 18:12 Tx date 2026-03-24 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+4,354 vol |
68,438 | |
| Filed 2026-03-17 10:58 Tx date 2025-12-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,030
+343 vol $11.75 each |
64,084 | |
| Filed 2026-03-17 10:57 Tx date 2025-12-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$24,944
+2,156 vol $11.57 each |
63,741 | |
| Filed 2025-03-31 18:11 Tx date 2025-03-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$34,520
+3,096 vol $11.15 each |
61,585 | |
| Filed 2025-03-31 18:08 Tx date 2025-03-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-6,192 vol |
58,489 | |
| Filed 2025-03-19 08:44 Tx date 2025-03-18 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+5,479 vol |
64,681 | |
| Filed 2025-03-11 12:12 Tx date 2024-12-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,281
+370 vol $8.87 each |
59,202 | |
| Filed 2025-03-11 12:10 Tx date 2024-12-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$24,903
+2,578 vol $9.66 each |
58,832 | |
| Filed 2024-12-16 14:39 Tx date 2024-12-13 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-68,138.40
-5,874 vol $11.60 each |
56,254 | |
| Filed 2024-12-16 14:38 Tx date 2024-12-13 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$56,390
+5,874 vol $9.60 each |
62,128 | |
| Filed 2024-12-16 14:36 Tx date 2024-12-13 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-56,390.40
-5,874 vol $9.60 each |
0 | |
| Filed 2024-12-12 10:30 Tx date 2024-12-12 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-55,628.75
-4,775 vol $11.65 each |
56,254 | |
| Filed 2024-12-12 10:28 Tx date 2024-12-12 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$39,250
+4,775 vol $8.22 each |
61,029 | |
| Filed 2024-12-12 10:26 Tx date 2024-12-12 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-39,250.50
-4,775 vol $8.22 each |
5,874 | |
| Filed 2024-03-27 19:20 Tx date 2024-03-27 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$57,689
+6,631 vol $8.70 each |
56,254 | |
| Filed 2024-03-20 09:08 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$31,246
+3,676 vol $8.50 each |
49,623 | |
| Filed 2024-03-20 09:07 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-7,352 vol |
45,947 | |
| Filed 2024-03-19 09:40 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,509
+454 vol $7.73 each |
53,299 | |